Search Results Search Sort by RelevanceMost Recent Viewpoint Nov 2002 Cultural Differences Intensify End-of-life Care Challenges Linda MacDonald Glenn, LLM and Faith Lagay, PhD Virtual Mentor. 2002;4(11):341-344. doi: 10.1001/virtualmentor.2002.4.11.elce1-0211. Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016;18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603. Podcast Apr 2022 Author Interview: “Should Clinicians Be Activists?” Dr Kristen N. Pallok joins Ethics Talk to discuss her article, coauthored with Dr David A. Ansell: “Should Clinicians Be Activists?” Case and Commentary Apr 2022 ¿Los médicos deben ser activistas? Kristen N. Pallok, MD and David A. Ansell, MD, MPH AMA J Ethics. 2022;E254-260. doi: 10.1001/amajethics.2022.254. Case and Commentary Jan 2016 Should Children be Asked to be Bone Marrow Donors for Siblings? Katrina Ann Williamson and Christian J. Vercler, MD, MA A patient- and family-centered approach can illuminate possible risks and benefits of bone marrow donation to child donors and sibling recipients. AMA J Ethics. 2016;18(1):18-23. doi: 10.1001/journalofethics.2017.18.1.ecas3-1601. Art of Medicine Feb 2023 Illuminating Psychological Torment of Child Abuse Paul R. Abramson, PhD and Tania L. Abramson, MFA This article considers 3 works by artists who were directly or indirectly affected by this type of childhood abuse. AMA J Ethics. 2023;25(2):E153-158. doi: 10.1001/amajethics.2023.153. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Policy Forum Nov 2022 Necessity for and Limitations of Price Transparency in American Health Care Harold A. Pollack, PhD, MPP More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline. AMA J Ethics. 2022;24(11):E1069-1074. doi: 10.1001/amajethics.2022.1069. In the Literature Oct 2002 Questioning the Voluntary Nature of Informed Consent Michelle Lim Virtual Mentor. 2002;4(10):302-304. doi: 10.1001/virtualmentor.2002.4.10.jdsc2-0210. Medical Education Oct 2002 Cultural Impasse Akshara Meran Virtual Mentor. 2002;4(10):305-307. doi: 10.1001/virtualmentor.2002.4.10.puhl1-0210. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Viewpoint Nov 2002 Cultural Differences Intensify End-of-life Care Challenges Linda MacDonald Glenn, LLM and Faith Lagay, PhD Virtual Mentor. 2002;4(11):341-344. doi: 10.1001/virtualmentor.2002.4.11.elce1-0211.
Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016;18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603.
Podcast Apr 2022 Author Interview: “Should Clinicians Be Activists?” Dr Kristen N. Pallok joins Ethics Talk to discuss her article, coauthored with Dr David A. Ansell: “Should Clinicians Be Activists?”
Case and Commentary Apr 2022 ¿Los médicos deben ser activistas? Kristen N. Pallok, MD and David A. Ansell, MD, MPH AMA J Ethics. 2022;E254-260. doi: 10.1001/amajethics.2022.254.
Case and Commentary Jan 2016 Should Children be Asked to be Bone Marrow Donors for Siblings? Katrina Ann Williamson and Christian J. Vercler, MD, MA A patient- and family-centered approach can illuminate possible risks and benefits of bone marrow donation to child donors and sibling recipients. AMA J Ethics. 2016;18(1):18-23. doi: 10.1001/journalofethics.2017.18.1.ecas3-1601.
Art of Medicine Feb 2023 Illuminating Psychological Torment of Child Abuse Paul R. Abramson, PhD and Tania L. Abramson, MFA This article considers 3 works by artists who were directly or indirectly affected by this type of childhood abuse. AMA J Ethics. 2023;25(2):E153-158. doi: 10.1001/amajethics.2023.153.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Policy Forum Nov 2022 Necessity for and Limitations of Price Transparency in American Health Care Harold A. Pollack, PhD, MPP More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline. AMA J Ethics. 2022;24(11):E1069-1074. doi: 10.1001/amajethics.2022.1069.
In the Literature Oct 2002 Questioning the Voluntary Nature of Informed Consent Michelle Lim Virtual Mentor. 2002;4(10):302-304. doi: 10.1001/virtualmentor.2002.4.10.jdsc2-0210.
Medical Education Oct 2002 Cultural Impasse Akshara Meran Virtual Mentor. 2002;4(10):305-307. doi: 10.1001/virtualmentor.2002.4.10.puhl1-0210.